Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shenzhen Zesum Technology
301486
5
Henan Shijia Photons Technology
688313
CN Stock MarketDetailed Quotes
000597 Northeast Pharmaceutical Group
- 5.48
- -0.10-1.79%
Trading Apr 25 13:59 CST
7.83BMarket Cap19.09P/E (TTM)
5.61High5.44Low185.80KlotVolume5.59Open5.58Pre Close102.01MTurnover1.32%Turnover Ratio19.09P/E (Static)1.43BShares6.6952wk High1.47P/B7.71BFloat Cap3.7252wk Low6.14Limit Up1.41BShs Float12.84Historical High5.02Limit Down3.05%Amplitude0.69Historical Low0.10Dividend TTM5.49Avg Price107.82KlotAsk1.82%Div YieldTTM100Lot Size76.88KlotBid
Northeast Pharmaceutical Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -20.93%4.47B | 7.96%5.08B | 27.02%4.89B | 48.16%5.82B | 46.98%5.65B | 3.83%4.7B | -4.03%3.85B | 30.05%3.93B | 50.76%3.84B | 70.98%4.53B |
| Notes receivable and accounts receivable | 4.02%2.49B | -3.40%2.63B | 0.07%2.8B | -5.41%2.61B | -5.39%2.4B | 2.77%2.72B | 2.96%2.8B | -1.45%2.76B | 6.89%2.53B | -1.06%2.65B |
| -Notes receivable | -8.39%534.62M | -11.57%524.75M | -2.95%531.05M | 6.57%593.93M | 4.46%583.58M | 20.79%593.4M | 25.00%547.22M | 16.76%557.32M | 6.40%558.66M | -25.29%491.25M |
| -Accounts receivable | 8.02%1.96B | -1.13%2.11B | 0.80%2.27B | -8.44%2.02B | -8.18%1.81B | -1.33%2.13B | -1.27%2.25B | -5.18%2.2B | 7.03%1.98B | 6.83%2.16B |
| Other receivables (including interest and dividends) | 0.66%192.51M | 38.15%286.85M | 15.39%238.69M | 20.28%251.51M | -2.39%191.25M | -50.19%207.64M | -52.17%206.86M | -49.50%209.1M | -50.04%195.93M | -5.50%416.89M |
| -Dividend receivable | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| -Accrued interest receivable | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | 0.66%192.51M | ---- | 15.39%238.69M | ---- | -2.39%191.25M | ---- | -52.17%206.86M | ---- | -50.04%195.93M | ---- |
| Contractual assets | -88.61%807.49K | -24.09%8.05M | 52.78%6.8M | 55.08%6.94M | 37.07%7.09M | -9.34%10.61M | 44.54%4.45M | 79.64%4.48M | -10.56%5.17M | 163.91%11.7M |
| Advance payment | -6.14%140.84M | 55.06%91.07M | -38.74%51.24M | 0.30%110.45M | 41.61%150.06M | -39.46%58.73M | -29.79%83.66M | -35.02%110.12M | -43.73%105.97M | -29.72%97.02M |
| Inventories | -2.95%1.32B | 2.02%1.27B | 3.47%1.4B | 4.57%1.43B | 11.77%1.36B | -4.21%1.25B | 1.86%1.36B | 6.99%1.37B | -2.15%1.22B | 31.27%1.3B |
| Other current assets | 19.66%26.52M | 16.04%37.13M | 3.44%34.32M | 16.66%25.63M | -8.72%22.16M | -0.75%31.99M | 5.37%33.18M | -43.11%21.97M | -45.89%24.28M | -23.34%32.24M |
| Total current assets | -11.62%8.65B | 4.69%9.41B | 13.11%9.43B | 22.06%10.26B | 23.36%9.78B | -0.63%8.98B | -3.64%8.34B | 8.77%8.4B | 16.64%7.93B | 21.41%9.04B |
| Non Current assets | ||||||||||
| Long-term equity investment | --6.13M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | -8.77%3.85B | ---- | -5.00%3.98B | ---- | -3.82%4.22B | ---- | -2.89%4.19B | ---- | -2.51%4.39B | ---- |
| Fixed assets liquidation | ---- | ---- | --19.18K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Constru in process | -31.42%111.6M | ---- | -47.22%201.8M | ---- | -60.39%162.73M | ---- | -40.97%382.33M | ---- | -38.94%410.79M | ---- |
| Construction materials | 21.43%43.88M | ---- | 335.40%38.64M | ---- | 233.06%36.14M | ---- | 8.75%8.88M | ---- | 91.47%10.85M | ---- |
| Intangible assets | 0.89%687.83M | -4.01%661.22M | -5.68%662.26M | -3.70%668.86M | -3.56%681.77M | 9.64%688.87M | 10.40%702.17M | 7.82%694.58M | 8.47%706.96M | -4.82%628.27M |
| Development expenditure | 402.89%717.74M | -0.02%140.14M | 9.62%145.76M | 1.99%148.34M | 17.34%142.72M | -56.41%140.16M | -57.64%132.97M | -52.70%145.44M | -59.49%121.63M | 3.31%321.55M |
| Goodwill | 491.33%154.45M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M | 0.00%26.12M |
| Long deferred expense | 3,163.03%24.31M | -8.57%744.66K | 1.64%606.3K | 5.25%675.69K | 2.21%745.07K | -41.01%814.46K | -34.16%596.54K | -58.22%641.99K | -67.55%728.93K | -6.48%1.38M |
| Deferred tax assets | 2.58%131.38M | 7.52%127.74M | 0.55%118.43M | 17.59%121.97M | 17.18%128.07M | 21.58%118.81M | 6.07%117.79M | -2.85%103.72M | 7.05%109.29M | 12.39%97.72M |
| Usufruct assets | 2.26%54.64M | -32.27%39.37M | -27.02%42.44M | -22.09%44.91M | 37.41%53.43M | 52.58%58.13M | 49.62%58.16M | 39.19%57.64M | -9.72%38.89M | -42.44%38.1M |
| Other non current assets | -59.48%13.97M | -28.33%28.09M | -47.83%27.33M | -49.42%30.56M | -44.99%34.47M | -50.84%39.2M | -16.78%52.39M | -29.14%60.42M | -12.16%62.66M | 9.59%79.73M |
| Total non current assets | 5.63%5.8B | -8.36%5.09B | -7.54%5.24B | -7.50%5.35B | -6.62%5.49B | -10.31%5.56B | -7.94%5.67B | -8.03%5.78B | -7.84%5.88B | -3.86%6.2B |
| Total assets | -5.42%14.45B | -0.30%14.5B | 4.75%14.67B | 10.01%15.61B | 10.60%15.27B | -4.57%14.54B | -5.42%14B | 1.23%14.19B | 4.79%13.81B | 9.69%15.24B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 19.51%1.54B | -7.94%1.48B | -14.28%1.58B | -26.26%1.57B | -31.43%1.29B | -42.31%1.61B | -30.07%1.84B | -1.22%2.13B | -8.20%1.88B | -6.04%2.79B |
| Notes payable and accounts payable | -16.22%4.84B | 3.20%5.02B | 7.57%5.03B | 33.93%5.82B | 33.73%5.78B | -1.58%4.86B | -3.00%4.68B | -1.05%4.34B | 16.90%4.32B | 39.95%4.94B |
| -Notes payable | -19.25%3.54B | 11.30%3.68B | 18.64%3.43B | 79.73%4.43B | 72.38%4.38B | 12.76%3.31B | -0.49%2.9B | 0.90%2.46B | 33.30%2.54B | 55.61%2.93B |
| -Accounts payable | -6.74%1.3B | -13.99%1.34B | -10.39%1.6B | -26.08%1.39B | -21.45%1.4B | -22.50%1.56B | -6.80%1.78B | -3.51%1.88B | -0.56%1.78B | 22.03%2.01B |
| Contract liabilities | -20.10%104.81M | -11.84%85.34M | -30.62%69.66M | -45.92%79.24M | -31.94%131.17M | 12.60%96.8M | 25.68%100.41M | 93.98%146.53M | 50.82%192.72M | -6.86%85.96M |
| Salaries payable | -13.63%46.25M | -10.13%2.04M | 74.71%4.21M | -80.82%2.39M | 326.87%53.55M | -35.08%2.26M | -32.83%2.41M | 194.28%12.44M | 237.36%12.55M | -1.73%3.49M |
| Taxs payable | -12.07%79.95M | -21.05%59.01M | -9.01%82.95M | -45.60%79.43M | -41.56%90.92M | -9.71%74.75M | 34.14%91.17M | 106.82%146.02M | 138.64%155.58M | 32.03%82.78M |
| Other payable (including interest and dividends) | 7.55%1.58B | -3.21%1.49B | -7.75%1.61B | -9.33%1.62B | -16.02%1.47B | 3.97%1.54B | 43.13%1.74B | 33.47%1.78B | 56.58%1.75B | 35.54%1.48B |
| -Interest payable | --0 | --1.57M | --750.39K | ---- | --0 | ---- | ---- | ---- | ---- | 5,672.40%3.36M |
| -Dividend payable | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M | 0.00%1.6M |
| -Other payable | 7.55%1.58B | --1.49B | -7.80%1.61B | ---- | -16.04%1.47B | ---- | 43.44%1.74B | ---- | 56.67%1.74B | 35.29%1.48B |
| Non current liabilities due within one year | -92.58%55.43M | 262.93%641.73M | 264.97%643.93M | 660.48%743.61M | 687.82%746.72M | -80.88%176.82M | -80.93%176.43M | -89.48%97.78M | -91.61%94.78M | 1.69%924.88M |
| Other current liabilities | -8.17%10.5M | -15.09%9M | -20.88%6.96M | -41.59%8.2M | -38.60%11.43M | -9.29%10.59M | 26.81%8.79M | 128.45%14.04M | 69.98%18.62M | 38.56%11.68M |
| Total current liabilities | -13.71%8.26B | 4.94%8.79B | 4.45%9.03B | 14.35%9.92B | 13.60%9.57B | -18.86%8.38B | -11.43%8.64B | -3.29%8.67B | 2.74%8.42B | 19.06%10.33B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | -44.00%78.4M | -67.06%78.4M | -36.97%150M | --740M | -30.00%140M | 19.00%238M | 19.00%238M | ---- |
| Deferred tax liabilities | 1,735.07%95.74M | -40.04%3.17M | -37.50%3.31M | -40.48%3.15M | -1.95%5.22M | -2.52%5.29M | -2.52%5.29M | -2.52%5.29M | -1.91%5.32M | -2.46%5.42M |
| Long term deferred income | -10.32%140.91M | -11.34%144.88M | -11.20%148.91M | -11.48%152.95M | -10.07%157.12M | -8.87%163.4M | -8.93%167.7M | -8.65%172.79M | -9.96%174.72M | -12.30%179.31M |
| Lease liabilities | -3.67%30.14M | -41.77%17.6M | -37.55%19.29M | -32.62%21.74M | 74.41%31.29M | 84.00%30.23M | 123.57%30.89M | 103.67%32.27M | -0.17%17.94M | -73.50%16.43M |
| Other non current liabilities | 73.98%352.83M | -15.97%185.2M | -15.97%185.2M | -14.79%202.8M | -14.79%202.8M | -13.77%220.4M | -13.77%220.4M | -12.88%238M | -12.88%238M | -12.10%255.6M |
| Total non current liabilities | 13.39%619.62M | -69.74%350.85M | -22.89%435.11M | -33.12%459.04M | -18.93%546.42M | 153.81%1.16B | -14.37%564.28M | 0.40%686.34M | -2.41%673.98M | -52.56%456.77M |
| Total liabilities | -12.24%8.88B | -4.13%9.14B | 2.78%9.46B | 10.87%10.37B | 11.19%10.11B | -11.55%9.54B | -11.61%9.2B | -3.03%9.36B | 2.34%9.1B | 11.90%10.78B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.43B | -0.36%1.43B | -0.36%1.43B | -0.36%1.43B | -0.36%1.43B | 0.70%1.43B | 6.41%1.43B | 6.41%1.43B | 6.41%1.43B | 5.68%1.42B |
| Capital reserve funds | 0.90%2.49B | 0.83%2.5B | 1.46%2.49B | 2.67%2.48B | 3.93%2.47B | 6.81%2.47B | 14.53%2.46B | 12.58%2.42B | 10.63%2.37B | 6.14%2.32B |
| Surplus reserve funds | 6.82%192.62M | 4.29%180.32M | 4.29%180.32M | 4.29%180.32M | 4.29%180.32M | 14.69%172.91M | 14.69%172.91M | 14.69%172.91M | 14.69%172.91M | 5.82%150.76M |
| Retained profit | 25.13%1.27B | 22.34%1.08B | 28.95%1.03B | 22.37%1.07B | 25.85%1.01B | 45.63%881.52M | 35.07%796.63M | 55.08%875.23M | 62.33%805.22M | 40.51%605.32M |
| Less:Treasury stock | -39.37%67.13M | -85.24%20.33M | -52.84%110.72M | -52.84%110.72M | -52.84%110.72M | -33.74%137.7M | --234.78M | --234.78M | --234.78M | --207.8M |
| Other composite income | 32.43%2.58M | -38.87%1.5M | -17.32%2.19M | 140.58%2.02M | 89.18%1.95M | 23.11%2.45M | 2,389.70%2.65M | 140.34%838.34K | 152.96%1.03M | 233.94%1.99M |
| Specific reserves | -1.05%6.39M | -0.69%6.44M | -0.96%6.44M | 0.74%6.46M | 5.14%6.46M | 12.28%6.49M | 21.13%6.5M | 29.29%6.41M | 33.62%6.14M | 65.28%5.78M |
| Shareholders equity without minority interests | 6.68%5.32B | 6.95%5.17B | 8.46%5.03B | 8.30%5.06B | 9.41%4.99B | 12.50%4.83B | 9.35%4.64B | 10.90%4.67B | 10.03%4.56B | 4.66%4.3B |
| Minority interests | 45.50%248.03M | 8.85%182.51M | 10.57%180.56M | 9.82%172.62M | 10.73%170.47M | 7.82%167.67M | 6.55%163.29M | 3.88%157.18M | 5.06%153.95M | 5.09%155.52M |
| Total shareholder equity | 7.97%5.57B | 7.01%5.35B | 8.53%5.21B | 8.35%5.23B | 9.45%5.16B | 12.34%5B | 9.25%4.8B | 10.65%4.83B | 9.86%4.71B | 4.67%4.45B |
| Total liabilityies and equity | -5.42%14.45B | -0.30%14.5B | 4.75%14.67B | 10.01%15.61B | 10.60%15.27B | -4.57%14.54B | -5.42%14B | 1.23%14.19B | 4.79%13.81B | 9.69%15.24B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs